Assessing Environmental Modifiers of Disease Risk Associated with Rare Mutations
- 1 February 2007
- journal article
- Published by S. Karger AG in Human Heredity
- Vol. 63 (2) , 134-143
- https://doi.org/10.1159/000099185
Abstract
As disease-predisposing mutations are increasingly identified, there is growing need to assess the effects of lifestyle and environmental factors on disease risks in mutation carriers. Such assessment is difficult when the mutations are rare and evaluating them in large population samples is costly. This paper describes four study designs for evaluating the effects of environmental exposures in carriers of rare disease-predisposing mutations. The strengths and weaknesses of the designs are assessed, and strategies for analyzing the data obtained from such designs are considered. When exposure effects in noncarriers are well-established and exposure is independent of carrier status in the population of disease-free controls, the case-only design provides a feasible and efficient method for inferring effects in carriers. When exposure effects in noncarriers are not well established, the most feasible design options are those that compare exposures in carrier cases to either untyped controls or to carrier controls. These two designs have complementary strengths and weaknesses; thus inferences are stronger when measures of association estimated using the two designs are consistent.Keywords
This publication has 23 references indexed in Scilit:
- The impact of population heterogeneity on risk estimation in genetic counselingBMC Medical Genetics, 2004
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- On the Use of Familial Aggregation in Population-Based Case Probands for Calculating PenetranceJNCI Journal of the National Cancer Institute, 2002
- Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2MutationNew England Journal of Medicine, 2001
- Oral Contraceptives and the Risk of Hereditary Ovarian CancerNew England Journal of Medicine, 1998
- BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast CancerNew England Journal of Medicine, 1997
- Childbearing, oral contraceptive use, and breast cancerThe Lancet, 1993
- Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of 12 US Case -Control StudiesAmerican Journal of Epidemiology, 1992
- Longitudinal Data Analysis Using Generalized Linear ModelsBiometrika, 1986
- Logistic Disease Incidence Models and Case-Control StudiesBiometrika, 1979